Dova Pharmaceuticals, Inc. Common Stock

DOVA

VANCOUVER, BC – October 7, 2025 – TheNewswire - Dova Health Intelligence Inc., a leader in AI-driven gastrointestinal disease assessment, is pleased to announce a collaboration with Mayo Clinic to advance the development and validation of DovaVision UC Mayo Endoscopic Score (MES) , an artificial intelligence tool designed for more precise and reproducible scoring of ulcerative colitis disease activity from colonoscopy videos.   Evaluating mucosal healing accurately is a critical element in the management of inflammatory bowel disease (IBD) and in clinical research. DovaVision UC MES applies computer vision and deep learning to standardize scoring and reduce variability in assessment, supporting informed decision-making for physicians and researchers.

LONDON & ONTARIO, Canada--(BUSINESS WIRE)--Alimentiv and Dova Health Intelligence announce the commercial availability of DovaVision, an endoscopy reading tool for UC clinical trials.